The large amount of evidence and the renewed interest in upper and lower airways involvement in infectious and inflammatory diseases has led Interasma (Global Asthma Association) to take a position on United Airways Diseases (UAD). Patients with UAD need to have a timely and adequate diagnosis, treatment, and, when recommended, referral for management in a specialised centre. Diagnostic testing including skin prick or serum specific IgE, lung function, fractional exhaled nitric oxide (FeNO), polysomnography, allergen-specific immunotherapies, biological therapies and home based continuous positive airway pressure whenever these are recommended, should be part of the management plan for UAD. This is a shortened version of the original article.
Modern Medicine – Issue 5 2021